IP Library Granted Patent US 10,940,090
Granted Patent B2
US 10,940,090 · App. 15/516,004 · Granted Mar 9, 2021

Syringe assembly

Inventors: Hannah Aiken (Surrey, GB); Chris Grimes (Surrey, GB); Aaron Hirschmann (Lake Geneva, WI); Robert Fesus (Lake Geneva, WI)
Assignee: Veriton Pharma Limited
A61J7/0053A61M2005/3104
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,940,090
App. No.
15/516,004
Granted
Mar 9, 2021
Kind
B2
Abstract

A syringe assembly ( 2 ) comprises a syringe barrel ( 4 ) comprising an inner chamber ( 14 ) filled or adapted to be filled with medicament, and a channel ( 18 ) in fluid communication with the chamber and through which medicament is dispensed. The assembly further comprises an outer sheath ( 6 ) configured to be removably attached to the syringe barrel, and comprising a projection ( 40 ) which is received by the channel when the outer sheath is attached to the barrel, thereby creating a seal, which prevents medicament from flowing therethrough.

Claims (23)

1. A syringe assembly comprising:

a syringe barrel comprising an inner chamber filled or adapted to be filled with a medicament, and a channel in fluid communication with the chamber and through which the medicament is dispensed from a distal end of the barrel; and

an outer sheath or cap, wherein the sheath or cap is a single contiguous structure configured to be removably attached to the syringe barrel, and comprising a projection disposed at a distal end of the sheath or cap, wherein the projection is received by the channel when the outer sheath or cap is attached to the barrel, thereby creating a first seal, which prevents medicament from flowing therethrough,

wherein the syringe barrel comprises a single engagement means disposed on an external surface thereof and located at a proximal end of the barrel, which is opposite the distal end of the barrel, and wherein the outer sheath or cap comprises a single engagement means disposed on an internal surface thereof and located at a proximal end of the sheath or cap, which is opposite the distal end of the sheath or cap, whereby the syringe barrel single engagement means and the outer sheath or cap single engagement means are configured to mutually engage with each other in order to create a second seal, which prevents leakage or discharge of the medicament from the chamber when the outer sheath or cap is attached to the barrel, and wherein the distal end of the syringe barrel does not comprise attachment means for connection to a medicament transfer means.

2. A syringe assembly according to claim 1 , wherein the attachment means is a projection and/or screw thread disposed at the distal end of the syringe barrel.

3. A syringe assembly according to claim 1 , wherein the engagement means comprise screw threads.

4. A syringe assembly according to claim 1 , wherein the syringe assembly is for administering medicament orally, buccally, sublingually, rectally, vaginally, topically or transdermally.

5. A syringe assembly according to claim 1 , wherein the syringe assembly is a buccal syringe assembly, which is used for administering the medicament to a patient's buccal cavity.

6. A syringe assembly according to claim 1 , wherein the syringe barrel is incompatible with a Luer lock or Luer slip.

7. A syringe assembly according to claim 1 , wherein the syringe barrel does not comprise an external screw thread at the distal end.

8. A syringe assembly according to claim 1 , wherein the distal end of the barrel comprises a plurality of spaced apart flanges, which extend from a side wall of the barrel and converge at the dispensing tip of the barrel to define an aperture which leads to the channel through which the medicament is dispensed, preferably wherein adjacent flanges are the same length so as to produce a substantially smooth profile.

9. A syringe assembly according to claim 1 , wherein the barrel comprises a transparent or translucent material.

10. A syringe assembly according to claim 1 , wherein the outer sheath or cap is configured to be removably attached to the syringe barrel to thereby encase at least a portion of the chamber, and preferably all of the chamber.

11. A syringe assembly according to claim 1 , wherein the outer sheath comprises an opaque material and/or an amber coloured material.

12. A syringe assembly according to claim 1 , wherein an external surface of the outer sheath is substantially smooth.

13. A syringe assembly according to claim 1 , wherein an external surface of the outer sheath or cap comprises one or more projections which extends transversely therefrom, and which is configured to facilitate removal of the outer sheath from the barrel, preferably wherein an external surface of the outer sheath comprises a plurality of spaced apart elongate ridges or protrusions, which extend along the longitudinal axis of the outer sheath or cap.

14. A syringe assembly according to claim 1 , wherein at least a portion of the external surface of the outer sheath or cap comprises a softened material, such as rubber or a suitable thermoplastic elastomer.

15. A syringe assembly according to claim 1 , wherein the syringe assembly is a single unit dose syringe assembly pre-filled with the medicament.

16. A syringe assembly according to claim 1 , wherein the medicament is selected from a group of medicaments consisting of: analgesics, anti-convulsants, antidepressants, vasodilators, steroids, opiate antagonists, anaesthetics, antiadrenergic compounds, antiallergic drugs, anti-anginals, anti-asthmatics, antibacterials, anti-coagulants, anti-cholinergics, antiemetics, antiepileptics, antihistaminics, antiinfectives, antiinflammatories, antimigraine drugs, bronchodilators, cardiac depressants, thrombolitics, beta blockers, opioids, sedatives, benzodiazepines and stimulants.

17. A syringe assembly according to claim 1 , wherein the medicament is selected from a group consisting of: midazolam, lorazepam, diazepam, paraldehyde, pentobarbital, morphine, carbamazepine, ethosuximide, clorazepate, clonazepam, felbamate, forphenytoin, gabapentin, lacosamide, lamotrigine, levetiracetam, oxacarbacepine, phenobarbital, phenytoin, pregabalin, primidone, tiagabine, topiramate, zonisamide, clobazam, vigabatrin, fentanyl, oxycodone, diamorphine, alprazolam, clonazepam, vasopressin, levetiracetam, and NSAIDs, or a salt thereof.

18. A syringe assembly according to claim 1 , wherein the syringe assembly is a unit dose syringe assembly pre-filled with midazolam or a salt thereof, such as midazolam maleate.

19. A syringe assembly according to claim 1 , wherein the syringe assembly comprises a plunger configured to slide in the chamber, preferably wherein the plunger comprises a rod having first and second ends, wherein the first end is inserted into the chamber, and the second end comprises a thumb tab, and the barrel comprises a finger tab, which is configured to be engaged with the finger of one hand while also engaging the thumb tab with the thumb of the same hand, more preferably wherein the syringe assembly comprises a transversely extending projection disposed on the side of the plunger rod, and an indentation disposed along the inside of the chamber, or vice versa, wherein alignment of the projection and indentation correlates with a defined volume of medicament and thereby a dosage.

20. A syringe assembly according to claim 1 , wherein the chamber is adapted to hold about 0.1-25 ml, or about 0.1-10 ml, or about 0.1-5 ml, or about 0.1-2 ml, or about 0.1-1 ml of the medicament.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 29, 2017
From: AIKEN, HANNAH; GRIMES, CHRIS
To: VERITON PHARMA LIMITED
Reel/Frame 044247/0670 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2017
From: HIRSCHMANN, AARON; FESUS, ROBERT
To: SPECIAL PRODUCTS LIMITED
Reel/Frame 044416/0354 →
CHANGE OF NAME Recorded Nov 9, 2017
From: SPECIAL PRODUCTS LIMITED
To: VERITON PHARMA LIMITED
Reel/Frame 044740/0623 →
Priority Claims (1)
GB 1417545 · Oct 3, 2014 · national
Continuity (1)
Related Publication 20170296434A1 · Oct 19, 2017